Caligan Partners’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-473,087
| Closed | -$2.14M | – | 13 |
|
|
2023
Q4 | $2.14M | Sell |
473,087
-124,426
| -21% | -$562K | 0.72% | 10 |
|
|
2023
Q3 | $2.14M | Sell |
597,513
-250,000
| -29% | -$895K | 0.98% | 8 |
|
|
2023
Q2 | $3.13M | Sell |
847,513
-815,100
| -49% | -$3.01M | 1.76% | 8 |
|
|
2023
Q1 | $5.5M | Sell |
1,662,613
-1,013,480
| -38% | -$3.35M | 3.84% | 6 |
|
|
2022
Q4 | $10.4M | Buy |
+2,676,093
| New | +$10.4M | 8.64% | 4 |
|